Baker Bros. Advisors LP X Biotech Inc. Transaction History

Baker Bros. Advisors LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$8.33 - $19.95 $4.34 Million - $10.4 Million	-521,327 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$6.86 - $10.46 $966,471 - $1.47 Million	140,885 Added 37.03%	521,327 $5.45 Million
Q2 2019 Aug 14, 2019	BUY	$6.99 - $11.27 $2.66 Million - $4.29 Million	380,442 New	380,442 $2.88 Million

4.87M

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $137M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Baker Bros. Advisors LP with notifications on news.